Navigation Links
US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
Date:1/7/2013

(PRWEB) January 07, 2013

The US Drug Watchdog is now saying, "It is counterintuitive to think a diabetes drug, designed to help diabetics deal with their illness, could also be responsible for bladder cancer because of the use of this specific medication, but this is exactly what we are saying. Unfortunately, the use of Actos for diabetes, and an elevated chance of bladder cancer could to be very related."

According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." The US Drug Watchdog says, "We now fear bladder cancer, and diabetics using the diabetes drug called Actos is a much bigger problem than we ever dreamed possible, and are urging all Actos users who now have bladder cancer to contact the Johnson Law Group at 1-800-996-9900." http://www.johnsonlawgroup.com/

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and hopefully suggesting possible help for victims, or the family members of victims." http://USDrugWatchdog.Com

Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10287139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Expands Their Efforts To Help Victims Of A Transvaginal Mesh Product Failure By Offering Victims The Names of National Caliber Women Attorneys
2. US Drug Watchdog Now Urges All Zimmer Stryker, Biomet, Wright and DePuy All Metal Hip Implant Recipients to Get A Blood Test For A Failure-Don't Get Left Holding the Bag
3. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
4. US Drug Watchdog Is Expanding Their Yaz-Yasmin Birth Control Pill Initiative and They Urge Victims to Contact the Johnson Law Group if They Had a Heart Attack or Stroke
5. US Drug Watchdog Now Expands Their Efforts to Help Victims of a Transvaginal Mesh Product Failure with a Focus on the Best Women Attorneys and Financial Compensation
6. US Drug Watchdog will Expand Their Initiative Focused on Helping Recipients of a Failed DePuy Pinnacle All Metal Hip Implant with a New Emphasis on Blood Testing in 2013
7. US Drug Watchdog Now Urges All US Recipients of an All Metal Hip Implant to Get a Blood Test for Cobalt-Chromium Levels and They Offer Victims of a Failure Legal Contacts
8. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh, Tape or Sling Failure The Names Of The Best Lawyers Who Will All Be Women-Because These Failures Involve Women
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Urges All DePuy Pinnacle Metal on Metal Hip Implant Recipients To Get A Blood Test and They Offer the Names of the Best Law Firms For Failure Victims
11. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 2017 , ... East Los Angeles dentist, Ramin Assili DDS , comments ... happens to a woman during pregnancy can have profound effects on a developing fetus, ... on a baby’s long-term health. This study, which was performed at the University of ...
(Date:6/26/2017)... Torrance, CA (PRWEB) , ... June 26, 2017 , ... ... treatments. Smile aesthetics can be one of the most noticeable aspects of a person’s ... approachable. While not everyone is born with beautiful, balanced teeth, everyone can have the ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
(Date:6/26/2017)... SALISBURY, MD. (PRWEB) , ... June 26, 2017 ... ... their crop, according to a recent review of government data released by the ... continuous improvement in management practices, Maryland’s soybean farmers have increased their productivity on ...
(Date:6/26/2017)... Lake Tahoe, CA (PRWEB) , ... June 26, 2017 , ... ... seeking 10,000 qualified mental health professionals in every state across the country to join ... an easy and rewarding way for therapists to reach a substantially greater number of ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: